Bolt Biotherapeutics - Stock Price History | BOLT

Historical daily share price chart and data for Bolt Biotherapeutics since 2021 adjusted for splits. The latest closing stock price for Bolt Biotherapeutics as of September 24, 2021 is 12.88.
  • The all-time high Bolt Biotherapeutics stock closing price was 39.93 on March 17, 2021.
  • The Bolt Biotherapeutics 52-week high stock price is 43.07, which is 234.4% above the current share price.
  • The Bolt Biotherapeutics 52-week low stock price is 10.75, which is 16.5% below the current share price.
  • The average Bolt Biotherapeutics stock price for the last 52 weeks is 20.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bolt Biotherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.480B $0.000B
Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71